D. Weng

Helper-Independent, L-Selectinlow CD8+ T Cells with Broad Anti-Tumor Efficacy Are Naturally Sensitized During Tumor Progression1

G. Plautz, P. Cohen, J. Kjaergaard, 2000, The Journal of Immunology.

The 2003 Revised TNM Staging System for Breast Cancer: Results of Stage Re-classification on Survival and Future Comparisons among Stage Groups

P. Escobar, L. Rybicki, J. Crowe, 2006, Annals of Surgical Oncology.

Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients.

S. Steinberg, M. Bishop, S. Kummar, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Angiozyme: A Novel angiogenesis inhibitor

D. Weng, Nassim Usman, 2001, Current oncology reports.

Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer

P. Escobar, L. Rybicki, J. Crowe, 2006, Annals of Surgical Oncology.

A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution.

P. Escobar, R. Tubbs, L. Rybicki, 2006, Breast.